This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Effector Therapeutics, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations by Takasuke Mukaiyama
Introduction
Takasuke Mukaiyama is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit eIF4e. His work has implications for various therapeutic applications, including the treatment of inflammation and cancers.
Latest Patents
Mukaiyama holds a patent for "EIF4E-inhibiting compounds and methods." This invention provides the synthesis, pharmaceutically acceptable formulations, and uses of compounds in accordance with Formula I, or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof. The inventive Formula I compounds are designed to inhibit eIF4e, showcasing their potential utility in therapeutic applications.
Career Highlights
He is currently associated with Effector Therapeutics, Inc., where he continues to advance his research and development efforts. His innovative work has led to the creation of a patent that addresses critical health issues, demonstrating his commitment to improving patient outcomes.
Collaborations
Mukaiyama collaborates with talented individuals in his field, including Samuel Sperry and Alan X Xiang. These partnerships enhance the research and development process, fostering an environment of innovation and discovery.
Conclusion
Takasuke Mukaiyama's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile